Testosterone Replacement Litigation Being Consolidated

Injury Attorneys | Restoring LivesTM

June 17, 2014 | Drug Injuries |

According to the U.S. Food and Drug Administration, an estimated 4 to 5 million American men may suffer from low testosterone, but only 5 percent are currently treated.

If you’ve watched TV in the last 12-months, you’ve seen a large number of commercials targeting men who suffer from “Low T”. The viewers are encouraged to speak with their doctor about “Low T” if they’re suffering from:

  • Low sex drive
  • Erectile dysfunction (ED)
  • Increased irritability or depression
  • Fatigue
  • Reduced muscle mass and strength
  • Inability to concentrate
  • Decreased bone density

On June 6, 2014, a panel of federal judges ordered all testosterone product lawsuits filed in federal courts to be centralized in the U.S. District Court for the Northern Illinois before one judge as part of a multidistrict litigation (MDL).

The market for testosterone replacement drugs is worth $1.6 billion annually. The consolidation will encompass all suits against makers of testosterone-replacement pills, including Indianapolis-based Eli Lilly and Co., the maker of AndroGel and Axiron.

According to a November 2013 study published in the Journal of the American Medical Association (JAMA), there was reported 30 percent rise in risk for stroke, heart attack, and death in men age 60 and older who had been prescribed testosterone.

Testosterone Replacement Side Effects:

  • Heart Attack
  • Stroke
  • Death
  • Pulmonary embolism (PE)
  • Deep vein thrombosis (DVT)

If you have taken a testosterone replacement medication and suffered one of the side effects noted above, please contact the drug injury lawyers at Wilson Kehoe Winingham. We’re currently investigating the injuries of those who have taken Low T medications. You may be entitled to compensation for your injuries.

Request A Free Case Evaluation

Submitting your information does not automatically create an attorney-client relationship. I agree